Genome Web Breaking News
- New Products Posted to GenomeWeb: Qiagen, Thermo Fisher, Bionano Genomics, BillionToOne, More
- People in the News at Illumina Ventures, Element Biosciences, Epigenomics, Exagen, More
- Genomic Approaches Boost Rare Disease Diagnoses in Middle Eastern Patient Population
- Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says
- Genome-Wide Analysis Sheds Light on Genetics of ADHD
Stat
- Federal panel approves plans to safeguard lab-made virus research
- STAT+: After bullying allegations, Eric Lander will return to run a lab at the Broad Institute
- STAT+: Pfizer is scolded by a U.K. trade group for remarks its CEO made about vaccination
- STAT+: Up and down the ladder: The latest comings and goings
- FDA eases rules again for gay men seeking to donate blood
NYT science news
- Expert Panel Votes for Stricter Rules on Risky Virus Research
- Deaths Among Pregnant Women and New Mothers Rose Sharply During Pandemic
- New Blood Donation Rules to Loosen Restrictions on Gay and Bisexual Men
- Why Experts Are Urging Swifter Treatment for Children With Obesity
- Polar Vortex Drives a Cold Snap in Asia
Fierce Biotech
- Researchers predict Alzheimer’s progression 3.5 years early with unique blood test
- Neither ear nor there: Altamira stakes for-sale sign again after asset deal crumbles
- Goldfinch Bio falls from the sky after failing to find a path forward for kidney treatments
- As ResMed tops $1B revenues in Q2, CEO says Philips’ return to the CPAP market is ‘not a big perturbation’ to long-term strategy
- Quince's former leadership returns to scoop up unwanted Alzheimer's assets
Fierce Medical Devices
- Researchers predict Alzheimer’s progression 3.5 years early with unique blood test
- As ResMed tops $1B revenues in Q2, CEO says Philips’ return to the CPAP market is ‘not a big perturbation’ to long-term strategy
- Ex-Neuralink exec’s brain implant startup Precision Neuroscience nets $41M
- Rockley Photonics files for bankruptcy, triggering NYSE delisting
- Abbott’s spinal cord stimulator nets FDA green light for diabetes pain